Forte Biosciences Inc (FBRX)
NasdaqCM · Biotechnology
Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.
Price history
Daily closes and volumeAI Analysis Generated from the indicator readings below. Educational only.
Forte Biosciences Inc is trading at $76.99, up 0.00% on the session. The 50 day average sits at $55.12 and the 200 day at $32.86, which puts the stock in a uptrend. RSI is at 84.4, which reads as overbought, and MACD is bearish crossover. Volume is below average.
The nearest support is around $76.82 with resistance near $77.20, so that band frames the current range. Average daily movement is roughly $1.08, or about 1.4% of the share price, which is what any stop placement has to allow for. The overall health score of 74 out of 100 combines a trend score of 100, momentum of 30 and a risk score of 92.
Technical indicators
About Forte Biosciences Inc
Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia areata; and services, including the clinical development and management of its Phase 2 clinical trials. Forte Biosciences, Inc. was incorporated in 2007 and is based in Dallas, Texas. As of August 27, 2026, Forte Biosciences, Inc. operates as a subsidiary of argenx SE.
Company website